by Sarah Lopez, MD, MBA & Stuart Swadron, MD on January 9, 2013
In October’s EMRAP, Dr. Sanjay Arora discussed procedural sedation and
analgesia (PSA) with Mel Herbert. Their discussion centered on ketofol,
the combination of ketamine and propofol, which has been proposed as an
ideal agent for PSA. The question of the hour: Could Ketofol be the
perfect drug?
In October’s EMRAP, Dr. Sanjay Arora discussed procedural sedation and
analgesia (PSA) with Mel Herbert. Their discussion centered on ketofol,
the combination of ketamine and propofol, which has been proposed as an
ideal agent for PSA. The question of the hour: Could Ketofol be the
perfect drug?
Columnists
Recent Comments
